How to Treat Hepatitis C Infection During Liver TransplantationHepatitis C Onset After Liver Transplantation

Your case is unique and falls into the category of a special type of hepatitis C, which can be very tricky to treat. Overall, the risks and benefits go hand in hand.

The treatment of hepatitis C in kidney transplantation, which has been reported internationally, is mainly interferon and/or low-dose ribavirin therapy. However, there are certain risks, i.e., the possibility of graft rejection, leading to transplant kidney failure. Internationally, the main reported drug i.e. short-acting interferon. However, in 2009, there was a literature report of 8 cases successfully treated with long-acting interferon. Two of these cases achieved complete eradication.

Similarly, the biggest risk of hepatitis C treatment after liver transplantation, and possible graft rejection after treatment, has been reported with a number of successes.

Currently, we have successfully treated one case of hepatitis C in kidney transplantation. Combined with the literature that has been reported, we believe that treatment (long-acting interferon) is still necessary in your case, but at some risk.

(Dr. Zheng Minghua solemn reminder: due to the inability to meet the patient, can not fully understand the condition, the above recommendations are for reference only, the specific diagnosis and treatment, please be sure to go to the hospital under the guidance of a doctor!)

Wenzhou Affiliated Hospital No. 1 Zheng Minghua /